Podcast Summary: "Is Designing Babies Unethical—or a Moral Imperative?"

Podcast: Honestly with Bari Weiss – The Free Press
Date: December 2, 2025
Host: Bari Weiss
Guests:

• Jamie Metzl (Tech & Healthcare Futurist, former WHO Expert Advisory Committee on Human Genome Editing)
• Dr. Alison Barrett (Veterinarian, Chief Science Officer, Foundation for Angelman Syndrome Therapeutics)
• Carter Sneed (Bioethicist, Law Professor, Notre Dame)
• Dr. Lydia Dugdale (Medical Ethicist & Physician, Columbia University)

Overview

This episode brings a deeply nuanced, passionate debate over the ethics and future of ‘designer babies’—the genetic selection and editing of embryos for specific traits, with a particular focus on disease prevention versus enhancement. With perspectives ranging from bioethics to lived experience as parents of children with genetic disorders, the panel weighs whether altering the genes of future generations is a moral responsibility, a noble use of medicine, or a dangerous foray into playing God.

Key Discussion Points & Insights

1. The State of Genetic Technology

• Somatic Editing vs. Germline Editing (00:04–07:00)

  • Somatic editing treats diseases in individual patients and is already being used clinically; effects are not inherited.
  • Germline editing changes the DNA in sperm/eggs or embryos—so edits are heritable—sparking much broader ethical concerns.

• Current Capabilities

  • Gene editing can now target deadly diseases both before and after birth.
  • Companies like Nucleus Genomics offer trait prediction and potential optimization even beyond disease, into intelligence and cosmetic traits.

• Real-World Example:

  • Mitochondrial transfer, approved after lengthy deliberation in the UK, has saved children from genetic death sentences (13:00).

2. Opening Statements

Jamie Metzl: (Pro, “Moral Imperative”, 08:19–14:53)

• Advocates for cautious, tightly regulated use of germline editing for serious, untreatable genetic conditions.
• Notable Quote:

  “Branding all potentially life saving and life affirming approaches that way today would be like calling agriculture unethical 10,000 years ago or calling vaccines unethical now.” (14:19)

• Stresses difference between reckless experimentation (like the CRISPR babies in China) and responsible science (08:30–13:00).

Carter Sneed: (Con, “Unethical”, 14:59–19:39)

• Distinguishes “designing” (engineering to spec) from “sorting” embryos; warns against making children projects rather than gifts to be welcomed unconditionally.
• Notable Quote:

  “A baby is a mysterious stranger that we welcome and love unconditionally. Our baby is a gift. And the fitting response to a gift is…gratitude, unconditional welcome, and love of another who is utterly dependent upon us…” (16:55)

• Supports ONLY proven, safe therapeutic interventions; warns of the slide from care to control (19:09).

Dr. Alison Barrett: (Pro, “Moral Imperative”, 19:39–26:10)

• Speaks from lived experience as a parent of a daughter with Angelman syndrome, emphasizing the life-changing power of gene therapy and the limitations of postnatal treatment.
• Notable Quote:

  “I don’t want another child. I want Quincy. I want her laughter, her humor, her kindness, and her essence. But free of the hardship of Angelman syndrome...” (22:00)

• Argues medicine is a moral imperative where suffering can be prevented responsibly.

Dr. Lydia Dugdale: (Con, “Unethical”, 26:10–33:32)

• Reminds that genetic “design” is ultimately an illusion of control, given complexity of genome AND microbiome.
• Draws strong historical parallels between modern genetic “optimization” and eugenics, warning of social and ethical dark sides.
• Notable Quote:

  “If some traits are desirable, then clearly other traits are not desirable. This is why the United States forcibly sterilized some 70,000 people...” (28:50)

• Raises profound disability justice and societal implications.

3. Safety, Regulation, and Slippery Slopes

Safety Concerns & Scientific Uncertainty

• Modern science cannot fully predict genome edits’ long-term consequences (35:00–37:00).
• Lydia:

  “We don’t understand how all genes... affect each other...there is zero chance we will ever be able to edit the DNA of the microbiome.” (26:37)

• All sides agree current tech is not “there yet” for broad clinical use.

Regulatory Risks

• US context is “the Wild West”—no strong regulation on trait selection (like sex) via PGD in IVF (48:07–49:52).
• Even with regulation, wealthy and international clients can evade restrictions (51:44–52:24).
• Real-world precedent: rapid, unregulated rollout of IVF, and the covert expansion of trait selection.

Slippery Slope

• Pro side: Believes careful, single-gene edits for dire disease could be limited by regulation.
• Con side: Once the door is opened, enhancement is inevitable and uncontrollable:

  “You will be able to buy your way, you will be able to extort your way, you’ll be able to find some way to do what you want to do.” (57:57, Lydia Dugdale)

4. Ethics: Definitions and Distinctions

What Counts as “Design”?

• Nearly all panelists agree disease-preventing edits (if someday safe) may be justifiable.
• “Designer babies” for non-medical traits (intelligence, physical features) seen as unethical and dangerous by all sides.

Lived Experience and Moral Compulsion

• Alison Barrett: Personalizes the debate—prefers to “fix” her daughter’s unique genome, not discard embryos or pursue “another child.”

  “If you wouldn’t hesitate to let me repair her malformed heart...why not let me repair her gene at the point with the highest chance of success?” (24:45)

Unconditional Love vs. Mastery

• Carter Sneed: Presses the ethical imperative to accept the “unbidden” in parenthood (16:58) and avoid commodification of children.

Cautionary Lessons from History

• Lydia Dugdale: Invokes past abuses (U.S. eugenics, Nazi atrocities) as reminders of the perils of defining worth by genetics (29:15).

Points of Convergence

• All agree that medical editing, when truly safe and strictly for disease, is at least potentially ethical.
• Deep skepticism about the realistic possibility of enforceable regulation preventing misuse.

5. Memorable Exchanges & Timestamps

• “Isn’t embryo selection already eugenics?” (Jamie Metzl, 40:55)
• Moral dilemma of “making just one change” to prevent deadly disease:
  • “If you think it’s ethical to change one gene...then you agree that it’s a moral imperative, not that everybody has to do it, but that some people be allowed to do it.” (Jamie Metzl, 42:51)
• Parental love vs. technical mastery:
  • “The more you introduce rational mastery, technical control manipulation into the procreative process, you're moving away from...welcoming and accepting your child in an unconditional way.” (Carter Sneed, 38:43)
• Slippery slope fears, regulation realism:
  • “Even if we get our safety pretty close, we will be opening the door to so many more unknowns by this going globally.” (Lydia Dugdale, 69:12)

6. Closing Statements

Jamie Metzl (Pro):

“If you believe it is ever ethical to make a single gene manipulation ... you have no choice but to vote for us.” (76:32)

Carter Sneed (Con):

"No one on this stage supports the creation of designer babies..."—reframes “designer” as something beyond disease prevention—and calls for rejection of open-ended child modification. (76:34)

Alison Barrett (Pro):

“If it is ethical to help treat a baby that has a devastating disorder that you couldn’t treat otherwise ... the answer is clear.” (77:51)

Lydia Dugdale (Con):

“Even if something is very carefully scripted...it won’t stay within the confines of this country...” (57:57)
“We need to be very cautious...before any undertaking of this sort takes place.” (80:10)

Takeaways & Audience Use

• Scientific lines are blurry: Even experts disagree where “disease prevention” ends and “enhancement” begins, and admit the technology for broad safe use is not here.
• History looms large: The memory of eugenics is ever-present; critics fear not just bad actors but a new era of inequity and commodification.
• Parental agony and hope: The human stories—parents desperate to save their children—cut through the abstraction, lending urgency and complexity to the debate.
• Consensus on caution, division on permission: All agree no one wants “designer babies” for trivial traits. The open question: Should “heritable” edits for health ever be allowed, and could they be contained?

Notable Quotes (with Timestamps)

• Jamie Metzl (14:19):

  “Branding all potentially life saving and life affirming approaches that way today would be like calling agriculture unethical 10,000 years ago or calling vaccines unethical now.”

• Carter Sneed (16:55):

  “A baby is a mysterious stranger that we welcome and love unconditionally. Our baby is a gift.”

• Alison Barrett (22:00):

  “I don’t want another child. I want Quincy. I want her laughter, her humor, her kindness, and her essence. But free of the hardship of Angelman syndrome...”

• Lydia Dugdale (28:50):

  “If some traits are desirable, then clearly other traits are not desirable. This is why the United States forcibly sterilized some 70,000 people...”

• Lydia Dugdale (57:57):

  “You will be able to buy your way, you will be able to extort your way, you’ll be able to find some way to do what you want to do.”

Timestamps for Key Segments

• Introduction & Scope: 00:02–07:06
• Debate Rules: 07:06–08:19
• Opening Statements: 08:19–33:32
• Nuanced Discussion, Ethics, Regulation: 33:48–74:08
• Closing Arguments: 74:30–81:55

Tone & Style

The conversation is rigorous, thoughtful, and respectful—even amid disagreement. Powerful personal stories, historical analogies, and technical explanations all draw out a debate that is as emotional as it is intellectual.

For Further Reflection

This episode is an excellent primer for anyone wrestling with the next wave of bioethics: Not just “can we?” but “should we?”—and “can we ever really draw the line?”
Share it, debate it with friends, and ask yourself: What kind of future do we want, and who gets to decide?